Research archive
Research published in 2005
16 publications from 2005, newest first.
Compiled automatically by Metronomic.com from PubMed and ClinicalTrials.gov. Automated listing. Each item links to its original source. Last refresh: Nov 15, 2026
Titles appear as published. A listing is not an endorsement, and a single study rarely settles a question. Not medically reviewed. Educational information, not medical advice.
- ReviewBreast2005 DecAnti-angiogenic treatment of breast cancer using metronomic low-dose chemotherapy.Munoz R, et al.
- Clinical trialJ Pediatr Hematol Oncol2005 NovA feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer.Kieran MW, et al.
- StudyClin Cancer Res2005 Sep 15Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510: a complementation antiangiogenic strategy.Yap R, et al.
- StudyCancer Res2005 Aug 15Low-dose metronomic combined with intermittent bolus-dose cyclophosphamide is an effective long-term chemotherapy treatment strategy.Shaked Y, et al.
- ReviewBull Cancer2005 Aug[Therapeutic strategies using VEGF inhibitors in colorectal cancer].Boige V, et al.
- StudyAnn Oncol2005 AugCyclophosphamide-methotrexate 'metronomic' chemotherapy for the palliative treatment of metastatic breast cancer. A comparative pharmacoeconomic evaluation.Bocci G, et al.
- StudyNeoplasia2005 JulContinuous low-dose (metronomic) chemotherapy on rat prostate tumors evaluated using MRI in vivo and comparison with histology.Zhao D, et al.
- StudyZhongguo Fei Ai Za Zhi2005 Jun 20[Antiangiogenic effect of continuous low-dose chemotherapy on Lewis lung carcinoma].Kang X, et al.
- StudyCell Death Differ2005 JunIn vivo upregulation of CD95 and CD95L causes synergistic inhibition of angiogenesis by TSP1 peptide and metronomic doxorubicin treatment.Quesada AJ, et al.
- ReviewExpert Opin Pharmacother2005 MayTreatment options in the management of ovarian cancer.Kikuchi Y, et al.
- StudyPhotochem Photobiol Sci2005 MayFluorescence image-guided brain tumour resection with adjuvant metronomic photodynamic therapy: pre-clinical model and technology development.Bogaards A, et al.
- ReviewOncology (Williston Park)2005 AprClinical implications of antiangiogenic therapies.Hudis CA
- StudyOncol Rep2005 AprVenous thromboembolism in colorectal cancer patients with central venous catheters for 5-FU infusion-based pharmacokinetic modulating chemotherapy.Yoshikawa R, et al.
- CommentaryAnn Oncol2005 AprReply to the article "Metronomic therapy with cyclophosphamide induces rat lymphoma and sarcoma regression, and is devoid of toxicity" by V. R. Rozados et al. (Ann Oncol 2004; 15: 1543-1550): ... and in humans?De Pas T, et al.
- ReviewCurr Treat Options Oncol2005 MarImatinib mesylate and its potential implications for gynecologic cancers.Dushkin H and Schilder RJ
- Clinical trialJ Neurooncol2005 FebUKT-04 trial of continuous metronomic low-dose chemotherapy with methotrexate and cyclophosphamide for recurrent glioblastoma.Herrlinger U, et al.